Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsRhonda Klein, MD, MPH
Assistant Clinical ProfessorAbout
Copy Link
Titles
Chief, Dermatology, Bridgeport Hospital
Biography
Dr. Rhonda Klein is an Assistant Professor of Dermatology, specializing in complex cutaneous diseases. She has a special interest in autoimmune diseases, including lupus erythematosus, dermatomyositis, and systemic sclerosis, as well as hereditary and autoimmune blistering diseases. During her training, she spent one year as a NIH research fellow focusing on rheumatologic dermatology to further her expertise on autoimmune cutaneous diseases. She has experience conducting investigator-initiated clinical trials and epidemiologic research that impact patients through the discovery of new therapies and policies. She also has expertise in tropical dermatology, having spent time on multiple occasions providing medical and dermatologic care in several areas of Africa. In addition to practicing at Yale Dermatology-Waterbury, she is the Chief of Dermatology at Bridgeport Hospital, where she runs the consultative dermatology service and outpatient dermatology clinic, as well as dermatology education for medical residents and students. She also serves as an editor for the monthly broadcast “Dialogues in Dermatology” of the Journal of the American Academy of Dermatology.
In addition to her expertise in medical dermatology, Dr. Klein is trained in both surgical and cosmetic dermatology and looks forward to treating her patients for all their skin care needs. She conducts thorough skin cancer screening examinations on a regular basis and counsels on preventing further skin cancers through appropriate sun avoidance and sunscreen use. She is adept at using systemic medications, including retinoids, methotrexate, cyclosporine, biologics, azathioprine, and mycophenolate mofetil. She is experienced with phototherapy, photodynamic therapy, botulinum toxin injections and fillers, as well as laser therapy for various dermatologic conditions, including the treatment of vascular lesions, scars, tattoos, hair removal, and solar lesions.
Dr. Klein provides care of patients with all medical, surgical, and cosmetic dermatologic conditions.
Dr. Klein received her B.A.S. and M.D. from the University of Pennsylvania and her M.P.H. from Columbia University. She completed her medical internship at Mount Sinai Medical Center in New York City and her dermatology residency at Yale-New Haven Hospital, where she served as Chief Resident during her final year.
Appointments
Dermatology 2
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
- Dermatology 2
- Yale New Haven Health System
Education & Training
- Resident
- Yale-New Haven Hospital (2011)
- Chief Resident
- Yale-New Haven Hospital (2011)
- Residency
- Yale New Haven Hospital (2011)
- Intern
- Mount Sinai Medical Center (2008)
- Internship
- Mount Sinai Medical Center (2008)
- MPH
- Columbia University, Public Health (2002)
- BAS
- University of Pennsylvania, Bioengineering / Biomedical Sciences (2001)
Research
Copy Link
Research at a Glance
Publications Timeline
Publications
2011
Symmetric Aplasia Cutis Congenita Associated with Fetus Papyraceus: Report of Two Cases
KLEIN RQ, ROBINSON DM, LIEBER CD, ANTAYA RJ. Symmetric Aplasia Cutis Congenita Associated with Fetus Papyraceus: Report of Two Cases. Pediatric Dermatology 2011, 28: 467-469. PMID: 21438917, DOI: 10.1111/j.1525-1470.2011.01314.x.Peer-Reviewed Original ResearchCitationsMeSH Keywords and Concepts
2010
Psoriatic Skin Lesions Induced by Certolizumab Pegol
Klein RQ, Spivack J, Choate KA. Psoriatic Skin Lesions Induced by Certolizumab Pegol. JAMA Dermatology 2010, 146: 1055-1056. PMID: 20855720, DOI: 10.1001/archdermatol.2010.225.Peer-Reviewed Original ResearchCitationsAurora kinase inhibitors as anti-cancer therapy
Lok W, Klein RQ, Saif MW. Aurora kinase inhibitors as anti-cancer therapy. Anti-Cancer Drugs 2010, 21: 339-350. PMID: 20016367, DOI: 10.1097/cad.0b013e3283350dd1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAntineoplastic AgentsAurora Kinase BAurora Kinase CAurora KinasesBenzamidesBenzimidazolesCyclohexanecarboxylic AcidsDrug Screening Assays, AntitumorEnzyme ActivationHumansNeoplasmsOrganophosphatesPhenylurea CompoundsProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyrazolesQuinazolinesThiazolesUreaConceptsNon-small cell lung cancerAurora kinase inhibitorsKinase inhibitorsCell lung cancerUpper gastrointestinal adenocarcinomasCurrent clinical investigationsAnti-cancer therapyAnti-tumor agentsOverview of inhibitorsGastrointestinal adenocarcinomasLung cancerAurora kinasesClinical investigationClinical settingHuman cancersCancer therapyTherapyCancerAurora AInhibitorsKey regulatorHuman aurora kinasesKinaseAurora BAdenocarcinoma
2009
Surgical Monotherapy Versus Surgery Plus Adjuvant Radiotherapy in High‐Risk Cutaneous Squamous Cell Carcinoma
Jambusaria‐PAHLAJANI A, MILLER CJ, QUON H, SMITH N, KLEIN RQ, SCHMULTS CD. Surgical Monotherapy Versus Surgery Plus Adjuvant Radiotherapy in High‐Risk Cutaneous Squamous Cell Carcinoma. Dermatologic Surgery 2009, 35: 574-584. PMID: 19415791, DOI: 10.1111/j.1524-4725.2009.01095.x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHigh-risk SCCAdjuvant radiotherapyClear surgical marginsDisease-specific deathPerineural invasionLocal recurrenceDistant metastasisSurgical marginsHigh-risk cutaneous squamous cell carcinomaCases of PNICutaneous squamous cell carcinomaHigh-risk featuresSurgical margin statusHigh cure ratesSquamous cell carcinomaOutcomes of interestNerve involvementMargin statusRegional metastasesCutaneous SCCWorse prognosisSCC casesSquamous cellsCell carcinomaCure rate
2007
Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. Journal Of The American Academy Of Dermatology 2007, 57: 937-43. PMID: 17923170, DOI: 10.1016/j.jaad.2007.08.024.Peer-Reviewed Original Research
Others
- Klein RQ, Bangert CC, Costner M, Connolly MK, Dugan E, Tanikawa A, Okawa J, Rose M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Troxel AB, Werth VP. Comparison of reliability and validity in the development of an outcome instrument forPeer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Honors
honor Mentorship Program Winner
National AwardMedical Dermatology SocietyDetailsUnited Stateshonor Advanced Resident Training & Education Award Recipient
National AwardOrlando Dermatology and Aesthetic & Clinical ConferenceDetailsUnited Stateshonor Alpha Omega Alpha National Medical Honor Society, Beta Chapter
National AwardDetailsUnited Stateshonor Dean’s List
Regional AwardUniversity of Pennsylvania School of Engineering & Applied ScienceDetailsUnited Stateshonor Hexagon, Penn Engineering Senior Honor Society
Regional AwardDetailsUnited States
News
Copy Link
Get In Touch
Copy Link